Skip to main content
. 2021 May 19;64(11):7312–7330. doi: 10.1021/acs.jmedchem.0c01806

Table 1. Biological Evaluation of Pyrimidines Derivatives on the Enzymatic Activity of Aurora A and Levels of MYC in MYC-Amplified Cancer Cells.

graphic file with name jm0c01806_0009.jpg

graphic file with name jm0c01806_0010.jpg

a

Values are the mean of 2–3 independent determinations ± SD (standard deviation).

b

Inhibition < 50% at 100 nM.

c

Relative protein level (mean ± SD) of cMYC in NCI-H82 and MYCN in SK-N-BE(2) under 1.0 μM of compound treatment. Experiments were undertaken in triplicate.